| View |
|
HRP-473-01
|
Oral Rehydration Salts
|
Genlyte
|
(See reverse for formulation)
|
Powder for Oral Solution (Orange Flavor)
|
Electrolytes and Carbohydrates
|
Saga Lifesciences Limited
|
India
|
-
|
06 September 2022
|
22 October 2026
|
| View |
|
DHRH-898
|
Carbocisteine
|
Fluifort-M
|
50 mg/mL
|
Suspension (Oral Drops)
|
Mucolytic
|
Lloyd Laboratories, Inc
|
Philippines
|
-
|
06 September 2022
|
25 October 2027
|
| View |
|
DRP-4164-33
|
Cefuroxime (as Axetil)
|
Goxime
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Brawn Laboratories Limited
|
India
|
-
|
06 September 2022
|
27 December 2027
|
| View |
|
DRP-4501-02
|
Levocetirizine Dihydrochloride
|
None
|
5 mg
|
Film-Coated Tablet
|
Antihistamines (Piperazine derivative)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
12 October 2022
|
28 June 2028
|
| View |
|
DRP-4507-07
|
Celecoxib
|
Lewicoxib
|
200 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
LifeSquare Laboratories, Inc.
|
Philippines
|
-
|
06 September 2022
|
04 October 2026
|
| View |
|
DRP-5052-21
|
Cefixime (as trihydrate)
|
Cefzin-S
|
100 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Third Generation Cephalosporin)
|
J.M. Tolmann Laboratories Inc..
|
Philippines
|
Initial (Variation)
|
16 August 2023
|
18 August 2027
|
| View |
|
DRP-7248-01
|
Levetiracetam
|
Levacetam
|
500 mg
|
Film Coated Tablet
|
Antiepileptic
|
Micro Labs Limited
|
India
|
-
|
16 February 2022
|
16 June 2025
|
| View |
|
DRP-5323-03
|
Aluminum Hydroxide + Magnesium Carbonate
|
Reflaxid
|
300 mg/200 mg
|
Chewable Tablet
|
Antacid
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
31 March 2023
|
04 March 2028
|
| View |
|
DRP-5365-01
|
Citicoline (as sodium)
|
Unbranded
|
500 mg
|
Film-Coated Tablet
|
Psychoanaleptic (Other psychostimulant and nootropic)
|
Innova Captab Limited
|
India
|
Renewal
|
24 January 2024
|
26 June 2029
|
| View |
|
DRP-6051-18
|
Ketoanalogues + Essential Amino Acids
|
Preveket
|
(See Reverse for Unit Dose Formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
25 July 2024
|
13 March 2030
|
| View |
|
DRP-6069-03
|
Tamsulosin Hydrochloride
|
Amkopros
|
400 mcg
|
Film-Coated Tablet
|
Alpha-adrenoreceptor Antagonist
|
Cooper Pharma Ltd
|
India
|
Renewal
|
25 August 2024
|
11 March 2030
|
| View |
DRP-6554-01_PI_01.pdf
|
DRP-6554-01
|
Mosapride Citrate
|
Gastorid
|
5 mg
|
Film-Coated Tablet
|
Gastroprokinetic
|
Aju Pharm Co., Ltd
|
Korea
|
-
|
06 September 2022
|
04 March 2026
|
| View |
|
DRP-8403-06
|
Cefuroxime (as Sodium)
|
Cefgen
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Second Generation Cephalosporin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Renewal
|
28 November 2023
|
15 February 2028
|
| View |
|
DRP-8914-03
|
Valsartan + Amlodipine (as besilate)
|
Valrexpin
|
160 mg/5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)/ Calcium Channel Blocker (CCB)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
06 August 2024
|
24 June 2030
|
| View |
|
DRP-9052-02
|
Meropenem (as trihydrate)
|
Merocent
|
1 g
|
Powder for Injection (IV)
|
Beta-lactam Antibacterial (Carbapenem)
|
Jeil Pharmaceutical Co., Ltd.
|
Korea
|
-
|
06 September 2022
|
31 October 2025
|
| View |
|
DRP-9136-01
|
Paracetamol
|
Portemp
|
150 mg/mL (300 mg/2 mL)
|
Solution for Injection (I.M./I.V.)
|
Analgesic/Antipyretic
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
-
|
06 September 2022
|
11 September 2025
|
| View |
|
DRP-9637-04
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Dontazo
|
4 g/500 mg
|
Powder for IV Infusion
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
-
|
06 September 2022
|
23 April 2026
|
| View |
|
DRP-10620-01
|
Azithromycin (as dihydrate)
|
Genzith
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Zim Laboratories Limited
|
India
|
-
|
06 September 2022
|
10 November 2026
|
| View |
|
DRP-10630-02
|
Vancomycin (as hydrochloride)
|
Vancocy
|
500 mg
|
Powder for Injection (IV)
|
Antibacterial (Glycopeptide)
|
Venus Remedies, Limited
|
India
|
-
|
06 September 2022
|
10 November 2026
|
| View |
|
DRP-10929-16
|
Norepinephrine (as bitartrate)
|
None
|
1mg/mL (4mg/4mL)
|
Solution for Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Makcur Laboratories Limited
|
India
|
-
|
06 September 2022
|
31 January 2027
|